Akari Therapeutics Plc ($AKTX)
Filing Information
| Accession Number | 0001493152-26-030210 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 26, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
18,830
Total Value
$105,006.11
P&L
+106.2% (+$111,538.89)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interim CFO | American Depositary Shares representing Ordinary Shares | โ | Jun 24, 2026 | Grant/Award | 1,248 | $10.02 | $12,504.96 | 2,870 | Direct | โ | View Details | |
Interim CFO | American Depositary Shares representing Ordinary Shares | โ | Jun 24, 2026 | Grant/Award | 1,395 | $9.32 | $13,001.40 | 4,265 | Direct | โ | View Details | |
Interim CFO | American Depositary Shares representing Ordinary Shares | โ | Jun 24, 2026 | Grant/Award | 1,570 | $8.28 | $12,999.60 | 5,835 | Direct | โ | View Details | |
Interim CFO | American Depositary Shares representing Ordinary Shares | โ | Jun 24, 2026 | Grant/Award | 2,539 | $5.12 | $12,999.68 | 8,374 | Direct | โ | View Details | |
Interim CFO | American Depositary Shares representing Ordinary Shares | โ | Jun 24, 2026 | Grant/Award | 3,725 | $3.49 | $13,000.25 | 12,099 | Direct | โ | View Details | |
Interim CFO | American Depositary Shares representing Ordinary Shares | โ | Jun 24, 2026 | Grant/Award | 7,353 | $3.74 | $27,500.22 | 19,452 | Direct | โ | View Details | |
Interim CFO | American Depositary Shares representing Ordinary Shares | โ | Jun 24, 2026 | Grant/Award | 1,000 | $13.00 | $13,000.00 | 20,452 | Direct | โ | View Details |